A5064998209- Inflammatory mediators and NSAID effects
- Drug-Induced Adverse Reactions
- Pain Management and Opioid Use
- Total Knee Arthroplasty Outcomes
- Pain Mechanisms and Treatments
- Synthesis of β-Lactam Compounds
- Pathogenesis and Treatment of Hiccups
- Gastroesophageal reflux and treatments
- Orthopedic Infections and Treatments
- Infectious Diseases and Tuberculosis
- Innovations in Medical Education
- Tuberculosis Research and Epidemiology
- Rheumatoid Arthritis Research and Therapies
- Pharmacology and Obesity Treatment
- Osteoarthritis Treatment and Mechanisms
- Autoimmune Bullous Skin Diseases
- Mycobacterium research and diagnosis
- Health Sciences Research and Education
- Anesthesia and Pain Management
- Contact Dermatitis and Allergies
- Polyomavirus and related diseases
- Head and Neck Surgical Oncology
- Eosinophilic Disorders and Syndromes
- Pharmacological Effects of Natural Compounds
- Pharmacogenetics and Drug Metabolism
Johns Hopkins University
2025
University of Pittsburgh
2024
Gentofte Hospital
2016
Arizona Department of Education
2011
Hôpital l'Archet
2001-2005
Purdue Pharma (Canada)
1996
Arizona Research Center
1990-1994
Phoenix (United States)
1994
University of Toronto
1992
Pfizer (United States)
1990
<h3>Background</h3> Although opioid analgesics have well-defined efficacy and safety in treatment of chronic cancer pain, further research is needed to define their role noncancer pain. <h3>Objective</h3> To evaluate the effects controlled-release oxycodone (OxyContin tablets) on pain function its vs placebo long-term use patients with moderate severe osteoarthritis <h3>Methods</h3> One hundred thirty-three experiencing persistent osteoarthritis-related for at least 1 month were randomized...
High-dose aspirin therapy for rheumatoid arthritis is frequently associated with severe gastrointestinal injury. To explore the possibility of reversing such damage, we conducted a double-blind, multicenter study misoprostol, prostaglandin E1 analog, which has demonstrated mucosal protective, gastric antisecretory, and ulcer healing properties. We also studied possible interference misoprostol continuing treatment in management patients arthritis. Patients confirmed endoscopically documented...
In an effort to expedite the publication of articles, AJHP is posting manuscripts online as soon possible after acceptance. Accepted have been peer-reviewed and copyedited, but are posted before technical formatting author proofing. These not final version record will be replaced with article (formatted per style proofed by authors) at a later time.
Non-steroidal anti-inflammatory drug (NSAID)-induced gastropathy is a serious public health problem. The United States Food and Drug Administration has recently proposed strong class labelling for NSAIDs, warning of the risk ulceration, bleeding perforation associated with their use. adaptation gastric mucosa in response to NSAID intake volunteers does not seem occur same extent rheumatic patients. In an ongoing study patients osteo or rheumatoid arthritis currently its fourth year,...
Clinical Pharmacology & Therapeutics (1996) 59, 129–129; doi: 10.1038/sj.clpt.1996.17
Journal Article In what circumstances is it justifiable to prescribe concomitant misoprostol and/or H2-receptor blockers with non-steroidal anti-inflammatory drugs? Get access S. H. Roth Medical Director, Professor and Director Search for other works by this author on: Oxford Academic PubMed Google Scholar Rheumatology, Volume 28, Issue 3, June 1989, Page 211, https://doi.org/10.1093/rheumatology/28.3.211 Published: 01 1989